4

Back to all posts

Press Release
AlphaLogix announces market release of AlphaFlo® canine allograft
AlphaFlo-Press-Release-Image

Equus Innovations, a manufacturer of advanced, next-generation veterinary regenerative products, in partnership with AlphaLogix, LLC (Argyle, Texas) announced today successful market release of a new canine allograft, AlphaFlo®.

You may want to read these articles

RenoVō® CASE STUDY: Puncture Wound

RenoVō® CASE STUDY: Puncture Wound

Case presentation - June 9, 2022: A three-year-old Quarter Horse filly backed into the catch for the stall door and punctured herself, creating a large, deep wound on her left thigh. The wound was sutured with internal and external stiches at clinic, however the...

RenoVō® CASE STUDY: Superficial Digital Flexor Tendon (RH)

RenoVō® CASE STUDY: Superficial Digital Flexor Tendon (RH)

Case presentation - June 9, 2016: A 9 year old Warmblood jumping horse presented with a superficial digital flexor tendon injury of the right hind leg. The horse was treated with stem cell injections. After 10 months of rest and rehabilitation, the horse slowly went...

RenoVō® CASE STUDY: Summer Sore

RenoVō® CASE STUDY: Summer Sore

Case presentation - June 17, 2022: A 19-year-old Red Horse presented to Topgun Veterinarian Service, Rock Hill, SC, with a large Summer Sore on the commissure of the right side of the mouth. The horse was treated orally with Ivermectin and topically with Ivermectin...